Fundz Deep Dive
Everything you need to win CBC Group and Mubadala Investment Company — in one platform.
Who to reach, what to say, and why now on CBC Group and Mubadala Investment Company — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on CBC Group and Mubadala Investment Company — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
CBC Group and Mubadala Partner with UCB in China for Neurology and Allergy Business Acquisition
Nov 30, 2024•over 1 year ago
Contract Type
partnership
ChinaHealth CareDescription
CBC Group, in partnership with Mubadala Investment Company, completed the acquisition of UCB's neurology and allergy business in China for US$680 million. This strategic move aims to establish CBC's presence in China's pharmaceutical market, particularly in the central nervous system (CNS) sector.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months